Integrin signaling links protein kinase Cepsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells
- PMID: 15467757
- DOI: 10.1038/sj.onc.1207900
Integrin signaling links protein kinase Cepsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells
Abstract
Failure of hormone therapy often involves an outgrowth of protein kinase Cepsilon (PKCepsilon)-positive cells in recurrent prostate cancer. Our previous investigations have uncovered evidence of a complex signaling network operating downstream of this oncogenic protein kinase to actively advance the survival and proliferation of prostate cancer cells. In this study, we present evidence of a functional interplay among integrin receptors, PKCepsilon, and protein kinase B (PKB/Akt) in recurrent CWR-R1 prostate cancer cells. Flow cytometry and confocal microscopy provided evidence that PKCepsilon signaling promoted the assembly of matrix adhesions containing an abundance of colocalized actin filaments and beta1 integrins that exhibited an exposed activation epitope on the surface of live CWR-R1 cells. Reciprocal coimmunoprecipitations provided evidence of signaling complexes containing PKCepsilon, beta1 integrins, Src, and PKB/Akt in CWR-R1 cell cultures. An investigation into the functional significance of these interactions, and of their positive influence on beta1 integrins, demonstrated that PKCepsilon and several key components of the PKB/Akt signaling pathway remain constitutively phosphorylated/activated in adherent but not suspension cultures of PTEN-positive CWR-R1 cells. Gene transfer, antisense and pharmacological experiments provided additional support for the hypothesis that a mutually reinforcing signaling loop sustains the activation of beta1 integrins, PKCepsilon, and PKB/Akt in adherent prostate cancer cells.
Similar articles
-
Regulation of caveolin-1 expression and secretion by a protein kinase cepsilon signaling pathway in human prostate cancer cells.J Biol Chem. 2002 Oct 25;277(43):40449-55. doi: 10.1074/jbc.M206270200. Epub 2002 Aug 15. J Biol Chem. 2002. PMID: 12185081
-
Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells.Oncogene. 2003 Sep 11;22(39):7958-68. doi: 10.1038/sj.onc.1206795. Oncogene. 2003. PMID: 12970744
-
Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway.J Biol Chem. 2003 Dec 12;278(50):50402-11. doi: 10.1074/jbc.M307627200. Epub 2003 Sep 30. J Biol Chem. 2003. PMID: 14523021
-
Integrin-linked kinase (ILK): a "hot" therapeutic target.Biochem Pharmacol. 2000 Oct 15;60(8):1115-9. doi: 10.1016/s0006-2952(00)00444-5. Biochem Pharmacol. 2000. PMID: 11007949 Review.
-
The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.Exp Cell Res. 1999 Nov 25;253(1):210-29. doi: 10.1006/excr.1999.4690. Exp Cell Res. 1999. PMID: 10579924 Review.
Cited by
-
Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells.Cancer Res. 2005 Aug 15;65(16):7301-9. doi: 10.1158/0008-5472.CAN-05-1064. Cancer Res. 2005. PMID: 16103081 Free PMC article.
-
Protein kinase C and cancer: what we know and what we do not.Oncogene. 2014 Nov 6;33(45):5225-37. doi: 10.1038/onc.2013.524. Epub 2013 Dec 16. Oncogene. 2014. PMID: 24336328 Free PMC article. Review.
-
Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer.Oncotarget. 2016 May 31;7(22):33069-80. doi: 10.18632/oncotarget.8850. Oncotarget. 2016. PMID: 27102301 Free PMC article.
-
FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2.EMBO J. 2006 Jul 12;25(13):3078-88. doi: 10.1038/sj.emboj.7601198. Epub 2006 Jun 29. EMBO J. 2006. PMID: 16810323 Free PMC article.
-
Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.Cancer Res. 2011 Mar 15;71(6):2318-27. doi: 10.1158/0008-5472.CAN-10-4170. Cancer Res. 2011. PMID: 21406403 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous